The novel coronavirus, recently, has been given the ability to mutate. And it has grown into a van for all mankind.
This is the 29th of January, and a total of 58 countries have reported strains of the virus.
In Brazil, researchers have found patients with two different strains of the virus.
In the United States, the first cases of South African strain have been detected. And in the UK, experts say, the vaccine may not be as effective on foreign lines.
The mutations are spreading, and diseases are rising. And new challenges are emerging as each day passes.
Here is a report.
BRAZIL
In Brazil, researchers have found patients with two different strains of the virus. The patients – both in their 30s were infected – with the first variant in November.
They have simultaneously tested postive for the second variant.
The symptoms were moderately mild, and the patients did not need hospitalization. But scientists say the facts confirm the many possible changes circulating in Brazil.
They put the joint in the same body accelerating mutations of other changes.
USA
In the United States, cases of the South African variety have been discovered for the first time. They were reported in two South Carolina adults – no travel history and no connection.
The focus has been on America ‘s ability to detect emerging rays.
Health experts are concerned – they are urging Americans to be more vigilant.
Dr. Brannon Traxler, South Carolina Interim Director of Public Health and Environmental Control (SCDHEC), said, “The future of Covid-19, of any change in South Carolina, this one includes, is another reminder that the fight against this deadly virus is far from over and we all need to be more vigilant about taking the preventative measures we know are working. “
BRITAIN
In the United Kingdom, Novavax has reported that the vaccine is 89 percent effective on the very infectious
a variety found in the country. But South African snoring is also spreading in the UK.
In particular, the vaccine is not very effective when it comes to this snoring.
Paul Heath, chief examiner of the UK Novavax trial from St George’s, University of London, said to date, “Now, it is not as effective as it is against UK variables and that could means changing the spike protein or indeed another part will now be considered to have added to the vaccine and Novavax is now doing that, and that may be the answer to a complete deal to, for example, the South African variety. “
As the coronavirus progresses, many virologists are looking at ways to help them recover from the virus. And we will wait.